[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356445-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356445-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","radiotherapy-plus-immune-checkpoint-inhibitors-versus-immune-checkpoint-inhibitors-alone-for-non-small-cell-lung-cancer-with-bone-metastases-a-systematic-review-and-meta-analysis-of-comparative-cohort-studies","Radiotherapy plus immune checkpoint inhibitors versus immune checkpoint inhibitors alone for non-small cell lung cancer with bone metastases - a systematic review and meta-analysis of comparative cohort studies","","Bone metastases are a frequent, clinically significant complication of advanced non-small cell lung cancer (NSCLC), contributing to morbidity and poor survival. This systematic review and meta-analysis compared radiotherapy (RT) plus immune checkpoint inhibitors (ICIs) versus ICI alone for NSCLC patients with radiologically or pathologically confirmed bone metastases. Six comparative cohort studies (n=1,631) were pooled to evaluate overall survival and progression-free survival as primary outcomes, with objective response rate, grade ≥3 adverse events, and skeletal-related events as secondary outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/radiotherapy-plus-immune-checkpoint-inhibitors-versus-immune-checkpoint-inhibitors-alone-for-non-small-cell-lung-cancer-with-bone-metastases-a-systematic-review-and-meta-analysis-of-comparative-cohort-studies/356445/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/radiotherapy-plus-immune-checkpoint-inhibitors-versus-immune-checkpoint-inhibitors-alone-for-non-small-cell-lung-cancer-with-bone-metastases-a-systematic-review-and-meta-analysis-of-comparative-cohort-studies/356445.png","ImageObject",300,407,{"name":42,"@type":43},"Rowan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What clinical question does the review address?","Question",{"text":63,"@type":64},"Whether adding radiotherapy to immune checkpoint inhibitors improves outcomes compared with immune checkpoint inhibitors alone in NSCLC patients with bone metastases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were studies identified and what time range was searched?",{"text":68,"@type":64},"PubMed, Cochrane Library, Web of Science, Scopus, and Embase were searched from January 2010 to October 2025 for comparative studies of RT + ICI versus ICI alone.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings for survival and safety?",{"text":72,"@type":64},"RT + ICI improved overall survival and progression-free survival versus ICI alone. Objective response rate and grade ≥3 adverse events were not significantly different, while skeletal-related events were reduced but based on sparse events.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356445,1790638840,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","TYPE Systematic Review PUBLISHED 19 February 2026  \nDOI 10.3389/fimmu.2026.1773998  \nOPEN ACCESS  \nEDITED BY  \nMokarram Hossain,  \nUniversity of Arkansas for Medical Sciences, United States  \nREVIEWED BY  \nYiwei Qin,  \nShandong Cancer Hospital, China Nithya Neelakantan,  \nUniversityof Arkansas for Medical Sciences, United States  \n*CORRESPONDENCE  \nTing Zhang  \n [zezht@zju.edu.cn](zezht@zju.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 23 December 2025  \nREVISED 29 January 2026  \nACCEPTED 03 February 2026  \nPUBLISHED 19 February 2026  \nCITATION  \nRuan Y, Cao W, Long C, Guo S, Han J, Chen Z and Zhang T (2026)  \nRadiotherapy plus immune checkpoint inhibitors versus immune checkpoint inhibitors alone for non-small cell lung cancer with bone metastases: a systematic review and meta-analysis of comparative cohort studies.  \nFront. Immunol. 17:1773998 .  \ndoi: 10.3389/fimmu.2026.1773998  \nCOPYRIGHT  \n© 2026 Ruan, Cao, Long, Guo, Han, Chen and Zhang. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRadiotherapy plus immune checkpoint inhibitors versus immune checkpoint inhibitors alone for non-small cell lung cancer with bone metastases:  \na systematic review and meta-analysis of comparative cohort studies  \nYingding Ruan 1†, Wenjun Cao 2†, Chuan Long 1, Siyu Guo 3, Jianwei Han 1, Zhendong Chen 4 and Ting Zhang 1,3*  \n1 Department of Thoracic Surgery, The First People’s Hospital of Jiande, Jiande, China, 2 Department of Thoracic Surgery, Afﬁliated Zhongshan Hospital of Dalian University, Dalian, China, 3 Radiotherapy Department, Second Afﬁliated Hospital, Zhejiang University School of Medicine, Hangzhou, China,  \n4 Department of Oncology, The First People’s Hospital of Jiande, Jiande, China  \nBackground: Bone metastases are a frequent and clinically consequential complication of advanced non-small cell lung cancer (NSCLC), associated with substantial morbidity and poor survival. Whether adding radiotherapy (RT) to immune checkpoint inhibitors (ICIs) improves outcomes remains uncertain. Methods: We searched PubMed, Cochrane Library, Web of Science, Scopus, and Embase (January 2010–October 2025) for comparative studies of RT + ICI versus ICI alone in patients with NSCLC and radiologically or pathologically conﬁrmed bone metastases. Primary outcomes were overall survival (OS) and progressionfree survival (PFS); secondary outcomes were objective response rate (ORR), grade ≥3 adverse events (AEs), and skeletal-related events (SREs) . Study quality was assessed using the Newcastle–Ottawa Scale. Hazard ratios (HRs) were pooled for time-to-event outcomes and odds ratios (ORs) for binary outcomes, using ﬁxed-or random-effects models according to heterogeneity.  \nResults: Six studies (n = 1,631) were included. RT + ICI improved OS (HR 0 . 58, 95% CI 0 .44–0.76; I² = 68%) and PFS (HR 0 .44, 95% CI 0 .37–0. 53; I² = 0%) versus ICI alone. The OS beneﬁt persisted after excluding the large database cohort (HR 0. 52, 95% CI 0 .42–0. 63) . ORR was not signiﬁcantly different (OR 1 . 68, 95% CI 0.77–3. 66; I² = 74%), and grade ≥3 AEs were comparable (OR 1 . 00, 95% CI 0 .78– 1. 27; I² = 0%) . RT + ICI reduced SREs (OR 0 . 16, 95% CI 0 .04–0. 68; I² = 0%), but this estimate is based on sparse events.  \nConclusions: Low-to moderate-quality observational evidence suggests that RT combined with ICIs may be associated with improved survival without an  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \napparent increase in severe toxicity in NSCLC with bone metastases. Any apparent reduction in SREs should be interpret","cbCaigKGM1bUVhag","https://ap.wps.com/l/cbCaigKGM1bUVhag","pdf",2929885,14,"English","# Background\n# Methods\n## Outcomes and study quality assessment\n# Results\n## Survival, response, toxicity, and skeletal-related events\n# Conclusions\n# Systematic Review Registration\n# Keywords\n# Introduction","[{\"question\":\"What clinical question does the review address?\",\"answer\":\"Whether adding radiotherapy to immune checkpoint inhibitors improves outcomes compared with immune checkpoint inhibitors alone in NSCLC patients with bone metastases.\"},{\"question\":\"How were studies identified and what time range was searched?\",\"answer\":\"PubMed, Cochrane Library, Web of Science, Scopus, and Embase were searched from January 2010 to October 2025 for comparative studies of RT + ICI versus ICI alone.\"},{\"question\":\"What were the main findings for survival and safety?\",\"answer\":\"RT + ICI improved overall survival and progression-free survival versus ICI alone. Objective response rate and grade ≥3 adverse events were not significantly different, while skeletal-related events were reduced but based on sparse events.\"}]","Radiotherapy plus immune checkpoint inhibitors versus immune checkpoint inhibitors alone for non-small cell lung cancer with bone metastases - a systematic review and meta-analysis of comparative cohort studies | PDF",1790125351,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/629d98f1bb8673466e060b96b35f7198.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffcb648076e9d813fecf52687c5cef3e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e90bf13fc5b7d9ad73f92892065b2b6.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23b812be3bcf6da127cacc73cc3c72d9.webp",980,1385]